Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Anticancer Research|August 27, 2011
Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluationGeorge Fountzilas, Helen P Kourea, Mattheos Bobos, et al.
Plos One|October 10, 2015
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) StudyGeorge Papaxoinis, Vassiliki Kotoula, Zoi Alexopoulou, et al.
Clinical Colorectal Cancer|July 8, 2018
AMALTHEA: Prospective, Single-Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First-Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal CancerGeorge Pentheroudakis, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Oncology Letters|December 6, 2021
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumabVassiliki Rapti, Evangelia Moirogiorgou, Georgia-Angeliki Koliou, et al.
BMC Medicine|February 2, 2011
A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: a Hellenic Cooperative Oncology Group studyChristos A Papadimitriou, Pavlos Papakostas, Maria Karina, et al.
Cancer Immunology, Immunotherapy : CII|April 19, 2020
Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?Triantafyllia Koletsa, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Plos One|August 1, 2018
Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trialAnna Goussia, Nafsika Simou, Flora Zagouri, et al.
Anticancer Research|May 29, 2023
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek PatientsHelena Linardou, Sofia Lampaki, Georgia-Angeliki Koliou, et al.
ESMO Open|August 21, 2020
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology GroupElena Fountzilas, Georgia-Angeliki Koliou, Athanassios Vozikis, et al.
Oncotarget|February 1, 2020
Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine InitiativeElena Fountzilas, Vassiliki Kotoula, Georgia-Angeliki Koliou, et al.
Pageof 11